Characteristics and outcomes of Stanford type A aortic dissection patients with severe post-operation hyperbilirubinemia: a retrospective cohort study
Open Access
- 28 July 2020
- journal article
- research article
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 15 (1) , 1-11
Abstract
Background: Hyperbilirubinemia is one of the common complications after cardiac surgery and is associated with increased mortality. However, to the best of our knowledge, the reports on clinical significance of postoperative severe hyperbilirubinemia in Stanford type A aortic dissection (AAD) patients were limited. Methods: Patients who underwent surgical treatment for AAD in our center between January 2015 and December 2018 were retrospectively screened. In-hospital mortality, long-term mortality, acute kidney injury (AKI), and the requirement of continuous renal replacement therapy (CRRT) were assessed as endpoints. Univariate and multivariate regression models were employed to identify the risk factors of these endpoints. Results: After screening, 271 patients were included in our present study. Of the included patients, 222 (81.9%) experienced postoperative AKI, and 50 (18.5%) received CRRT. The in-hospital mortality was 30.3%. The 1-year, 2-year, and 3-year cumulative mortality were 32.9, 33.9, and 35.3%, respectively. Multivariate Logistic regression analysis indicated that age (P < 0.033), AKI stage 3 (P < 0.001), the amount of blood transfusion after surgery (P = 0.019), mean arterial pressure (MAP) in the first postoperative day (P = 0.012), the use of extracorporeal membrane oxygenation (ECMO) (P = 0.02), and the peak total bilirubin (TB) concentration (P = 0.023) were independent risk factors of in-hospital mortality. The optimal cut-off value of peak TB on predicting in-hospital mortality was 121.2 μmol/L. Patients with post-operation TB ≥ 121 μmol/L was associated with worse long-term survival as well. Conclusions: Severe post-operation hyperbilirubinemia is a common clinical situation in patients had AAD repair. In AAD patients with severe post-operation hyperbilirubinemia, older age, lower MAP, increased blood transfusion, stage 3 AKI, the use of ECMO, and the increased peak TB lead to increase in-hospital mortality.Keywords
All Related Versions
Funding Information
- The National Natural Science Foundation of China (81700584)
- Discipline promotion project of Xijing hospital (XJZT18ML16)
This publication has 37 references indexed in Scilit:
- Rat Cerebellar Slice Cultures Exposed to Bilirubin Evidence Reactive Gliosis, Excitotoxicity and Impaired Myelinogenesis that Is Prevented by AMPA and TNF-α InhibitorsMolecular Neurobiology, 2013
- Frequency, Risk Factors and Prognosis of Postoperative Hyperbilirubinemia after Heart Valve SurgeryCardiology, 2012
- Hemolysis and ECMO pumps in the 21st CenturyPerfusion, 2010
- Postoperative Hyperbilirubinemia Is an Independent Predictor of Longterm Outcomes after Cardiopulmonary BypassJournal of the American College of Surgeons, 2008
- Incidence, risk factors, and prognosis of postoperative hyperbilirubinemia after heart transplantationEuropean Journal of Cardio-Thoracic Surgery, 2007
- Perioperative risk factors for mortality in patients with acute type a aortic dissectionThe Annals of Thoracic Surgery, 2002
- Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trialLiver Transplantation, 2000
- Jaundice after open heart surgery: a prospective study.Thorax, 1984
- INCIDENCE AND PROGNOSTIC IMPORTANCE OF JAUNDICE AFTER CARDIOPULMONARY BYPASS SURGERYThe Lancet, 1983
- Early jaundice after open-heart surgeryThorax, 1967